title: Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector.
abstract: Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, generating so-called induced pluripotent stem cells (iPSCs)(1-4). Patient-specific iPSCs lack the ethical concerns that surround embryonic stem cells (ESCs) and would bypass possible immune rejection. Thus, iPSCs have attracted considerable attention for disease modeling studies, the screening of pharmacological compounds, and regenerative therapies(5). We have shown the generation of transgene-free human iPSCs from patients with different lung diseases using a single excisable polycistronic lentiviral Stem Cell Cassette (STEMCCA) encoding the Yamanaka factors(6). These iPSC lines were generated from skin fibroblasts, the most common cell type used for reprogramming. Normally, obtaining fibroblasts requires a skin punch biopsy followed by expansion of the cells in culture for a few passages. Importantly, a number of groups have reported the reprogramming of human peripheral blood cells into iPSCs(7-9). In one study, a Tet inducible version of the STEMCCA vector was employed(9), which required the blood cells to be simultaneously infected with a constitutively active lentivirus encoding the reverse tetracycline transactivator. In contrast to fibroblasts, peripheral blood cells can be collected via minimally invasive procedures, greatly reducing the discomfort and distress of the patient. A simple and effective protocol for reprogramming blood cells using a constitutive single excisable vector may accelerate the application of iPSC technology by making it accessible to a broader research community. Furthermore, reprogramming of peripheral blood cells allows for the generation of iPSCs from individuals in which skin biopsies should be avoided (i.e. aberrant scarring) or due to pre-existing disease conditions preventing access to punch biopsies. Here we demonstrate a protocol for the generation of human iPSCs from peripheral blood mononuclear cells (PBMCs) using a single floxed-excisable lentiviral vector constitutively expressing the 4 factors. Freshly collected or thawed PBMCs are expanded for 9 days as described(10,11) in medium containing ascorbic acid, SCF, IGF-1, IL-3 and EPO before being transduced with the STEMCCA lentivirus. Cells are then plated onto MEFs and ESC-like colonies can be visualized two weeks after infection. Finally, selected clones are expanded and tested for the expression of the pluripotency markers SSEA-4, Tra-1-60 and Tra-1-81. This protocol is simple, robust and highly consistent, providing a reliable methodology for the generation of human iPSCs from readily accessible 4 ml of blood.
authors.affiliation: Center for Regenerative Medicine (CReM), Boston University School of Medicine.
authors.forename: Andreia Gianotti
authors.initials: AG
authors.lastname: Sommer
authors.forename: Sarah S
authors.initials: SS
authors.lastname: Rozelle
authors.forename: Spencer
authors.initials: S
authors.lastname: Sullivan
authors.forename: Jason A
authors.initials: JA
authors.lastname: Mills
authors.forename: Seon-Mi
authors.initials: SM
authors.lastname: Park
authors.forename: Brenden W
authors.initials: BW
authors.lastname: Smith
authors.forename: Amulya M
authors.initials: AM
authors.lastname: Iyer
authors.forename: Deborah L
authors.initials: DL
authors.lastname: French
authors.forename: Darrell N
authors.initials: DN
authors.lastname: Kotton
authors.forename: Paul
authors.initials: P
authors.lastname: Gadue
authors.forename: George J
authors.initials: GJ
authors.lastname: Murphy
authors.forename: Gustavo
authors.initials: G
authors.lastname: Mostoslavsky
mesh_terms: D000954:Antigens, Surface / Q000096:biosynthesis; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D000090062:Kruppel-Like Factor 4; D016086:Lentivirus / Q000235:genetics*; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D039904:Pluripotent Stem Cells / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D011509:Proteoglycans / Q000096:biosynthesis; D055746:Stage-Specific Embryonic Antigens / Q000096:biosynthesis; D014161:Transduction, Genetic
chemical_list: D000954:Antigens, Surface; C000715467:KLF4 protein, human; D000090062:Kruppel-Like Factor 4; D011509:Proteoglycans; D055746:Stage-Specific Embryonic Antigens; C107064:TRA-1-60 antigen, human; C519803:TRA-1-81 antigen, human; C066584:stage-specific embryonic antigen-4